David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.27% |
| 2 | Consumer Discretionary | 13.7% |
| 3 | Healthcare | 13.3% |
| 4 | Industrials | 7.34% |
| 5 | Financials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
PUT
EOG Resources
EOG
$78B
| $9.59M | 0.01% |
102,900
+9,200
| +10% | +$856K |
|
1127
Halozyme
HALO
$12.3B
| $9.51M | 0.01% |
553,386
+233,400
| +73% | +$3.77M |
|
1128
Arthur J. Gallagher & Co
AJG
$69.3B
| $9.51M | 0.01% |
108,512
+75,327
| +227% | +$6.29M |
|
1129
CALL
Norfolk Southern
NSC
$79.2B
| $9.49M | 0.01% |
47,600
+26,200
| +122% | +$5.2M |
|
1130
Tactile Systems Technology
TCMD
$529M
| $9.45M | 0.01% |
165,941
-88,038
| -35% | -$4.59M |
|
|
DISCK
1131
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $9.44M | 0.01% |
+331,888
| New | +$9.01M |
|
|
B
1132
Barrick Mining
B
$79.8B
| $9.43M | 0.01% |
598,037
+101,097
| +20% | +$1.34M |
|
1133
PUT
Verizon
VZ
$208B
| $9.43M | 0.01% |
165,000
-281,600
| -63% | -$16.2M |
|
|
AKRX
1134
DELISTED
Akorn Inc
AKRX
| $9.42M | 0.01% |
1,828,657
+63,897
| +4% | +$246K |
|
|
GCP
1135
DELISTED
GCP Applied Technologies Inc.
GCP
| $9.41M | 0.01% |
415,655
-90,561
| -18% | -$2.44M |
|
1136
CALL
Essex Property Trust
ESS
$18.8B
| $9.4M | 0.01% |
32,200
+10,000
| +45% | +$2.88M |
|
|
HES
1137
DELISTED
Hess
HES
| $9.39M | 0.01% |
147,755
+132,235
| +852% | +$8.18M |
|
1138
Silicon Laboratories
SLAB
$7.27B
| $9.38M | 0.01% |
90,717
+19,351
| +27% | +$1.87M |
|
|
GTS
1139
DELISTED
Triple-S Management Corporation
GTS
| $9.38M | 0.01% |
413,251
+12,028
| +3% | +$273K |
|
1140
Tyson Foods
TSN
$20.2B
| $9.35M | 0.01% |
115,816
+16,161
| +16% | +$1.24M |
|
1141
PUT
Stellantis
STLA
$19.7B
| $9.33M | 0.01% |
675,000
+100,000
| +17% | +$1.45M |
|
|
FLG
1142
Flagstar Bank National Association
FLG
$5.55B
| $9.33M | 0.01% |
+311,479
| New | +$10.1M |
|
1143
Calix
CALX
$2.51B
| $9.31M | 0.01% |
1,419,090
+234,719
| +20% | +$1.58M |
|
1144
CALL
Sarepta Therapeutics
SRPT
$1.99B
| $9.28M | 0.01% |
61,100
-20,000
| -25% | -$2.43M |
|
1145
Hilltop Holdings
HTH
$2.21B
| $9.26M | 0.01% |
435,538
-65,900
| -13% | -$1.33M |
|
|
CSII
1146
DELISTED
Cardiovascular Systems, Inc.
CSII
| $9.26M | 0.01% |
215,810
-177,803
| -45% | -$6.9M |
|
1147
CALL
Factset
FDS
$10.7B
| $9.26M | 0.01% |
32,300
+14,000
| +77% | +$3.87M |
|
1148
First Horizon
FHN
$11.6B
| $9.25M | 0.01% |
+619,276
| New | +$8.96M |
|
|
BLUE
1149
PUT
DELISTED
bluebird bio
BLUE
| $9.22M | 0.01% |
5,597
+1,737
| +45% | +$3M |
|
1150
PUT
Illumina
ILMN
$33.8B
| $9.2M | 0.01% |
25,700
+7,093
| +38% | +$2.24M |
|
Similar funds
David Shaw's Q2 2019 Portfolio in Review
As of Q2 2019, David Shaw held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- David Shaw added most to Alibaba in Q2 2019, an estimated $667M increase.
- David Shaw's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- David Shaw's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- David Shaw opened 499 new positions and closed 416 in Q2 2019.
- David Shaw's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.